Catalyst Wire Dossier Catalyst Wire Dossier

rIX-FP

recombinant coagulation factor IX albumin fusion protein · CSL Behring
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for rIX-FP, covering 2022-07-14 to 2026-07-23. Get the full timeline:

Most recent: Clinical Trial Update: Recombinant Fusion Protein Linking Coagulation Factor IX With Albumin (rIX-FP) in Chinese Subjects With Hemophilia B Previously Treated With FIX Therapy [Phase 3]

See pricing